Cardiotoxic	cardiotoxic	S_chemicals	O
and	and	O	O
possible	possible	O	O
leukemogenic	leukemogenic	O	O
effects	effects	O	O
of	of	O	O
adriamycin	adriamycin	O	O
in	in	O	O
nonhuman	nonhuman	O	O
primates.10	primates.10	O	O
monkeys	monkeys	O	O
(	(	O	O
macaques	macaques	O	O
)	)	O	O
received	received	O	O
adriamycin	adriamycin	O	O
by	by	O	O
monthly	monthly	O	O
intravenous	intravenous	O	O
injections	injections	O	O
at	at	O	O
12	12	O	O
mg/m2	mg/m2	O	O
(	(	B_chemicals	O
1	1	I_chemicals	O
mg/kg	mg/kg	O	O
)	)	O	O
.	.	O	O

8	8	O	O
of	of	O	O
the	the	O	O
10	10	O	O
monkeys	monkeys	O	O
developed	developed	O	O
congestive	congestive	O	B_disease
heart	heart	O	B_disease
failure	failure	O	I_disease
at	at	O	O
an	an	O	O
average	average	O	O
cumulative	cumulative	O	O
adriamycin	adriamycin	O	O
dose	dose	O	O
(	(	O	O
310	310	O	O
mg/m2	mg/m2	O	O
)	)	O	O
well	well	O	O
below	below	O	O
that	that	O	O
considered	considered	O	O
the	the	O	O
safe	safe	O	O
upper	upper	O	O
limit	limit	O	O
(	(	O	O
550	550	O	O
mg/m2	mg/m2	O	O
)	)	O	O
in	in	O	O
man	man	O	O
.	.	O	O

Histologically	histologically	O	O
,	,	O	O
the	the	O	O
myocardial	myocardial	O	O
lesions	lesions	O	O
resembled	resembled	O	O
those	those	O	O
found	found	O	O
in	in	O	O
human	human	O	O
anthracycline-induced	anthracycline-induced	O	O
cardiomyopathy	cardiomyopathy	O	S_disease
.	.	O	O

1	1	O	O
of	of	O	O
the	the	O	O
10	10	O	O
monkeys	monkeys	O	O
developed	developed	O	O
acute	acute	O	B_disease
myeloblastic	myeloblastic	O	B_disease
leukemia	leukemia	O	S_disease
after	after	O	O
receiving	receiving	O	O
324	324	O	O
mg/m2	mg/m2	O	O
of	of	O	O
adriamycin	adriamycin	O	O
;	;	O	O
the	the	O	O
10th	10th	O	O
monkey	monkey	O	O
is	is	O	O
alive	alive	O	O
and	and	O	O
well	well	O	O
26	26	O	O
months	months	O	O
after	after	O	O
the	the	O	O
last	last	O	O
dose	dose	O	O
of	of	O	O
drug	drug	S_chemicals	O
.	.	O	O

Our	our	O	O
results	results	O	O
suggest	suggest	O	O
that	that	O	O
adriamycin	adriamycin	O	O
is	is	O	O
a	a	O	O
more	more	O	O
potent	potent	O	O
cardiotoxin	cardiotoxin	S_chemicals	O
in	in	O	O
monkeys	monkeys	O	O
than	than	O	O
in	in	O	O
man	man	O	O
,	,	O	O
and	and	O	O
that	that	O	O
leukemia	leukemia	O	S_disease
may	may	O	O
be	be	O	O
a	a	O	O
consequence	consequence	O	O
of	of	O	O
prolonged	prolonged	O	O
treatment	treatment	O	O
with	with	O	O
this	this	O	O
drug	drug	S_chemicals	O
.	.	O	O

